These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 9112751

  • 1. Pharmacotherapy for acid/peptic disorders.
    Schubert ML.
    Yale J Biol Med; 1996; 69(2):197-201. PubMed ID: 9112751
    [Abstract] [Full Text] [Related]

  • 2. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C.
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [Abstract] [Full Text] [Related]

  • 3. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
    Holtmann G, Layer P, Goebell H.
    Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
    [Abstract] [Full Text] [Related]

  • 4. Proton pump inhibitors and acid-related diseases.
    Sachs G.
    Pharmacotherapy; 1997 May; 17(1):22-37. PubMed ID: 9017763
    [Abstract] [Full Text] [Related]

  • 5. Lansoprazole: a comprehensive review.
    Zimmermann AE, Katona BG.
    Pharmacotherapy; 1997 May; 17(2):308-26. PubMed ID: 9085323
    [Abstract] [Full Text] [Related]

  • 6. Proton pump inhibitory therapy: then and now.
    Schepp W.
    Yale J Biol Med; 1996 May; 69(2):175-86. PubMed ID: 9112749
    [Abstract] [Full Text] [Related]

  • 7. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD.
    Yale J Biol Med; 1996 May; 69(3):211-24. PubMed ID: 9165690
    [Abstract] [Full Text] [Related]

  • 8. [Recent studies on therapy of peptic ulcers].
    Asaka M.
    Nihon Naika Gakkai Zasshi; 1999 Sep 10; 88(9):1750-4. PubMed ID: 10581758
    [No Abstract] [Full Text] [Related]

  • 9. From nerves and hormones to bacteria in the stomach; Nobel prize for achievements in gastrology during last century.
    Konturek SJ, Konturek PC, Brzozowski T, Konturek JW, Pawlik WW.
    J Physiol Pharmacol; 2005 Dec 10; 56(4):507-30. PubMed ID: 16391411
    [Abstract] [Full Text] [Related]

  • 10. An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazole.
    Bown RL.
    Int J Clin Pract; 2002 Mar 10; 56(2):132-9. PubMed ID: 11926700
    [Abstract] [Full Text] [Related]

  • 11. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
    Bardou M.
    Rev Prat; 2001 Apr 15; 51(7):789-95. PubMed ID: 11387678
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ, Hunt RH.
    Best Pract Res Clin Gastroenterol; 2001 Jun 15; 15(3):355-70. PubMed ID: 11403532
    [Abstract] [Full Text] [Related]

  • 13. Control of gastric acid secretion in health and disease.
    Schubert ML, Peura DA.
    Gastroenterology; 2008 Jun 15; 134(7):1842-60. PubMed ID: 18474247
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Is the successful eradication of Helicobacter pylori sufficient for the healing of peptic ulcer?].
    Pregun I, Herszényi L, Juhász M, Miheller P, Tulassay Z.
    Orv Hetil; 2006 Mar 12; 147(10):435-9. PubMed ID: 16573172
    [Abstract] [Full Text] [Related]

  • 17. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
    Lazzaroni M, Bianchi Porro G.
    Ital J Gastroenterol Hepatol; 1999 Mar 12; 31 Suppl 1():S73-8. PubMed ID: 10379473
    [Abstract] [Full Text] [Related]

  • 18. Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications.
    Robinson M.
    Aliment Pharmacol Ther; 2004 Nov 12; 20 Suppl 6():1-10. PubMed ID: 15496213
    [Abstract] [Full Text] [Related]

  • 19. [Helicobacter pylori infection. The Spanish consensus report. The Spanish Consensus Conference Group].
    Sainz R, Borda F, Domínguez E, Gisbert JP.
    Rev Esp Enferm Dig; 1999 Nov 12; 91(11):777-84. PubMed ID: 10601771
    [Abstract] [Full Text] [Related]

  • 20. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S, Keleş H, Ozkurt ZN, Cengiz DU, Kolukisa E.
    Turk J Gastroenterol; 2005 Mar 12; 16(1):29-33. PubMed ID: 16252185
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.